Julie Johnson, PharmD, is the Director and Principal Investigator at The Ohio State University Clinical and Translational Science Institute.
Ohio CTSAs Collaborative Review Article Featured in NEJM Evidence
The recently published review article in NEJM Evidence highlights collaboration between two Ohio Clinical and Translational Science Award (CTSA) hubs. Co-authored by Julie A. Johnson, Pharm.D., director of The Ohio State University Clinical and Translational Science Institute and Ohio State’s CTSA PI, and Nihal El Rouby, Pharm.D., Ph.D., a KL2 Scholar at the University of Cincinnati’s Center for Clinical and Translational Science and Training, the review manuscript reflects the strength of statewide partnerships in advancing translational research. Their joint contribution highlights Ohio’s leadership in clinical and translational science and the impact of cross-institutional collaboration.
